Analysis of Endocrine and Metabolic Indexes in Non-Obese Patients with Polycystic Ovary Syndrome and Its Compare with Obese Patients

Código QR

Analysis of Endocrine and Metabolic Indexes in Non-Obese Patients with Polycystic Ovary Syndrome and Its Compare with Obese Patients

Wenjing Shi, Qi Zhao, Xue Zhao, Chuan Xing, Bing He Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, People’s Republic of ChinaCorrespondence: Bing He Email hb3h@hotmail.comPurpose: To compare the endocrine and metabolic indexes of obese and normal body mass ind...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shi W, Zhao Q, Zhao X, Xing C, He B
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	polycystic ovary syndrome insulin resistance obesity hyperandrogenemia endocrine metabolism Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/76605326ba9a4a04b3eb6627c9439f8c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
por: Ran Y, et al.
Publicado: (2021)

METABOLIC AND NUTRITIONAL INTERFACES IN POLYCYSTIC OVARY SYNDROME: CONSIDERATIONS REGARDING OBESITY AND DIETARY MACRONUTRIENTS
por: Rodrigues de O. P.,Fernanda, et al.
Publicado: (2009)

Correlation Between Daily Energy Intake from Fat with Insulin Resistance in Patients with Polycystic Ovary Syndrome
por: Zheng X, et al.
Publicado: (2021)

A Comparative Study on Insulin Secretion, Insulin Resistance and Thyroid Function in Patients with Polycystic Ovary Syndrome with and without Hashimoto’s Thyroiditis
por: Zhao H, et al.
Publicado: (2021)

MODERN CONCEPTS OF THE PATHOGENESIS OF POLYCYSTIC OVARY SYNDROME (LITERATURE REVIEW)
por: O. V. Panarina, et al.
Publicado: (2017)

Obesity Exacerbates Irritable Bowel Syndrome-Related Sleep and Psychiatric Disorders in Women With Polycystic Ovary Syndrome
por: Ping-Huei Tseng, et al.
Publicado: (2021)

Does endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome?
por: Rajani Dube
Publicado: (2016)

Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review
por: Carvalho Laura M. L., et al.
Publicado: (2018)

Decreased serum profile of the interleukin-36α in polycystic ovary syndrome
por: Semra Eroglu, et al.
Publicado: (2021)

Molecular Mechanisms of Endometrial Functioning in Women with Polycystic Ovary Syndrome
por: A. Yu. Sambyalova
Publicado: (2021)

ASSOCIATION OF ANEMIA WITH SERUM SEX HORMONE BINDING GLOBULIN LEVELS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME
por: Hafiza Swaiba Afzal, et al.
Publicado: (2020)

Comparison of Flutamide and Metformin in Overweight-Obese Women with Polycystic Ovary Syndrome Following a Hypocaloric Dieting
por: S Esmaeilzadeh, et al.
Publicado: (2010)

Polycystic ovary syndrome - 80 years of research and new directions in the study (literature review)
por: L. V. Damdinova, et al.
Publicado: (2016)

Dieta baja en carbohidratos y dieta cetogénica: impacto en enfermedades metabólicas y reproductivas
por: Moreno-Sepúlveda,José, et al.
Publicado: (2020)

Identification of Genetic Variants for Female Obesity and Evaluation of the Causal Role of Genetically Defined Obesity in Polycystic Ovarian Syndrome
por: Ahn Y, et al.
Publicado: (2020)

Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study
por: Congcong Jin, et al.
Publicado: (2021)

The Impact of COVID-19 Lockdown on Weight Loss Program in Infertile Polycystic Ovary Syndrome Women with Obesity
por: Ana Šuštaršič, et al.
Publicado: (2021)

Association Between Menstrual Patterns and Adverse Pregnancy Outcomes in Patients With Polycystic Ovary Syndrome
por: Ting Yu, et al.
Publicado: (2021)

Prevalencia familiar de patologías metabólicas en pacientes con síndrome de ovario poliquístico
por: Benítez M,Ricardo, et al.
Publicado: (2001)

The Genetic Association of Polycystic Ovary Syndrome and the Risk of Endometrial Cancer: A Mendelian Randomization Study
por: Hanxiao Chen, et al.
Publicado: (2021)

Effects of Different Methods of Laparoscopic Ovarian Drilling and its Outcome in Patients with Polycystic Ovary Syndrome
por: Mona Hamoda, et al.
Publicado: (2021)

Neck circumference as a predictor of obesity and metabolic syndrome in bangladeshi women with polycystic ovary syndrome
por: A B M. Kamrul-Hasan, et al.
Publicado: (2021)

Effect of the Treatment with Dexamethasone, for 10 and 15 Days, on the Fertility in Induced Rats to Polycystic Ovaries, by Constant Illumination
por: Moraes,Eleonora de Figueiredo, et al.
Publicado: (2008)

Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial
por: Haiqing Qian, et al.
Publicado: (2021)

Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome
por: Murat Gözüküçük, et al.
Publicado: (2021)

Trichology features of alopecia in reproductive age women with polycystic ovary syndrome
por: L. V. Belenkaya, et al.
Publicado: (2017)

Efficacy of spironolactone in adult acne in polycystic ovary syndrome patients an original research
por: Neha Rani, et al.
Publicado: (2021)

Features of Chronic Endometritis in Women of Reproductive Age with Polycystic Ovary Syndrome
por: E. M. Sharifulin, et al.
Publicado: (2021)

Decreased Endometrial Thickness Is Associated With Higher Risk of Neonatal Complications in Women With Polycystic Ovary Syndrome
por: Jialyu Huang, et al.
Publicado: (2021)

Evaluation of the Estral Cycle in Rats after Treatmen twith Dexamethasone for Polycystic Ovaries, Induced by Constant Illumination
por: Barros,Heitor Arôxa, et al.
Publicado: (2006)

Obesity in Patients with Type 1 Diabetes: Links, Risks and Management Challenges
por: Vilarrasa N, et al.
Publicado: (2021)

ASSOCIATION OF ANEMIA WITH SERUM SEX HORMONE BINDING GLOBULIN LEVELS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME
por: Hafiza Swaiba Afzal, et al.
Publicado: (2020)

The features of the process of lipid peroxidation and antioxidant protection in women of reproductive age diagnosed with polycystic ovary syndrome (literature review)
por: O. V. Panarina
Publicado: (2018)

Clasificación de los fenotipos de síndrome de ovario poliquístico de acuerdo a los criterios de Rotterdam: ¿una condición estática o variable?
por: Echiburú,Bárbara, et al.
Publicado: (2014)

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Publicado: (2009)

Raman Spectrum of Follicular Fluid: A Potential Biomarker for Oocyte Developmental Competence in Polycystic Ovary Syndrome
por: Xin Huang, et al.
Publicado: (2021)

A Common 34C>G Variant at the Peroxisome Proliferator-Activated Receptor γ2- Gene in Chilean Women with Polycystic Ovary Syndrome and Controls
por: Guzmán,Neftalí, et al.
Publicado: (2007)

Barberry in the treatment of obesity and metabolic syndrome: possible mechanisms of action
por: Firouzi S, et al.
Publicado: (2018)

How Western Diet And Lifestyle Drive The Pandemic Of Obesity And Civilization Diseases
por: Kopp W
Publicado: (2019)

Plasma cholinesterase is associated with Chinese adolescent overweight or obesity and metabolic syndrome prediction
por: Han Y, et al.
Publicado: (2019)